Indiana University Dermatology Clinical Research

06/13/2026

You have tried the oils, the supplements, and the treatments your doctor recommended. Some worked for a while. Most did not. And every morning you check the mirror, wondering if today is the day it spreads again.

That uncertainty is exhausting. And it is exactly what drives the research we do at Indiana University.

Our Alopecia Areata clinical trial is now open in Indianapolis. No cost to participate, and you might be compensated for your time and travel. We are waiting to hear from you.

06/11/2026

Melanoma is one of the most serious skin cancers, but when caught early, it's also one of the most treatable. The ABCDE method takes less than 2 minutes and could make all the difference.

Do a full check once a month. Know your normal. Notice what changes.
And if something feels off? Trust your gut and get it looked at.

IU Dermatology Clinical Trials is based in Indianapolis with locations across Indiana. Tap the link in our bio to learn more about our research studies.

06/08/2026

Joining a clinical trial at IU Dermatology is more straightforward than most people might think, and you're never navigating it alone. From that first screening call to your final visit, our team is with you every step of the way.

We're currently enrolling for conditions including vitiligo, alopecia areata, lupus, and more. Study-related care is covered, and no insurance is required.

Tap the link in our bio to explore open studies and see if you qualify.

06/05/2026

Lupus is a chronic autoimmune condition in which the immune system mistakenly attacks healthy tissues, affecting the skin, joints, kidneys, and other organs. It most commonly occurs as systemic lupus erythematosus (SLE). Globally, lupus affects an estimated 5 million people, with a significantly higher prevalence in women, especially those of reproductive age (15–45 years). It is also more common and often more severe in individuals of African, Asian, and Hispanic descent, highlighting important genetic and environmental influences on the disease. To learn more about lupus and how it is diagnosed, read the blog linked below.

Learn how lupus is diagnosed through blood tests, symptom review, imaging and clinical criteria doctors use to confirm autoimmune disease accurately

06/02/2026

Early signs of vitiligo can be subtle, but recognizing them early can make a difference in management and care. From tiny, depigmented spots to early hair whitening, your skin often gives you clues. If you notice unusual changes in skin color, don’t ignore them. Awareness is the first step toward understanding your skin better.

To know more, visit us at:
https://dermatrials.medicine.iu.edu/clinical-research-studies/vitiligo-clinical-trials

05/31/2026

Hair loss isn’t always just about hair. Alopecia areata is our body sending signals from within, often linked to immunity, genetics, and triggers we don’t always see.

The more we understand the “why,” the better we can respond with care, not confusion.

05/25/2026

They gave everything so we could move forward. Today, we pause to honor their sacrifice. Happy Memorial Day from all of us at IU Dermatology Research.

05/23/2026

Hair loss isn’t one-size-fits-all. From temporary shedding to long-term conditions, each type of alopecia has a different cause and understanding it can make all the difference.
Let's break down the most common types to help you recognize the signs and know when to seek the right guidance.
For more information, visit us at:
https://dermatrials.medicine.iu.edu/clinical-research-studies/alopecia-areata-clinical-trials

05/21/2026

Back in 1747, James Lind changed medicine forever when he asked a simple question and invited twelve sailors to help find the answer. While science has evolved over the last 280 years, the heart of what we do at IU remains unchanged.

We see every clinical trial as a world of care, curiosity, and collaboration working together toward something greater. Inside that world are researchers asking better questions, clinical teams protecting every step, and participants whose trust gives science its purpose.

Today, we celebrate the people who make that world possible. It is your courage and commitment that turn scientific possibility into real human progress. We are proud to be part of this journey with you.

05/19/2026

Atopic Dermatitis clinical trials follow carefully defined eligibility criteria to ensure participant safety and accurate research outcomes. These criteria often consider diagnosis, severity, treatment history, and overall health.

Since every study is different, requirements may vary. To know more, visit us at:
https://dermatrials.medicine.iu.edu/clinical-research-studies/atopic-dermatitis-clinical-trials